Disseminated, nonmeningeal gastrointestinal cryptococcal infection in an HIV-negative patient.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 2220742)

Published in Am J Gastroenterol on October 01, 1990

Authors

J S Daly1, K A Porter, F K Chong, R J Robillard

Author Affiliations

1: Department of Medicine, St. Elizabeth's Hospital, Boston, Massachusetts.

Articles by these authors

(truncated to the top 100)

Evolution of liver transplantation. Hepatology (1982) 19.54

Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11

The use of cyclosporin A and prednisone in cadaver kidney transplantation. Surg Gynecol Obstet (1980) 7.40

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

Fifteen years of clinical liver transplantation. Gastroenterology (1979) 7.19

Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95

Orthotopic homotransplantation of the human liver. Ann Surg (1968) 6.64

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74

Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53

Extended survival in 3 cases of orthotopic homotransplantation of the human liver. Surgery (1968) 5.44

Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24

Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08

The preparation and testing of horse antidog and antihuman antilymphoid plasma or serum and its protein fractions. Surg Gynecol Obstet (1967) 3.86

The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84

Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74

Transplantation of multiple abdominal viscera. JAMA (1989) 3.59

Canine liver transplantation under Nva2-cyclosporine versus cyclosporine. Transplantation (1986) 3.54

Cadaveric renal transplantation. An analysis of 65 cases. Lancet (1969) 3.48

Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). Ann Surg (1970) 3.48

Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40

Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26

Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26

Chronic survival after human renal homotransplantation. Lymphocyte-antigen matching, pathology and influence of thymectomy. Ann Surg (1965) 3.00

Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients. Surg Gynecol Obstet (1981) 2.92

Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum (1969) 2.80

Growth-stimulating factor in regenerating canine liver. Lancet (1979) 2.61

Studies of blood flow and ultrastructural changes in rejecting and nonrejecting canine orthotopic liver homografts. Surgery (1968) 2.58

Detection of circulating immune complexes in pathological human sera. Lancet (1975) 2.51

Liver transplantation, 1980, with particular reference to cyclosporin-A. Transplant Proc (1981) 2.49

Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg (1978) 2.48

Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44

Hepatotrophic effects of FK506 in dogs. Transplantation (1991) 2.39

The Eck fistula in animals and humans. Curr Probl Surg (1983) 2.35

Cloning and sequence analysis of the rat augmenter of liver regeneration (ALR) gene: expression of biologically active recombinant ALR and demonstration of tissue distribution. Proc Natl Acad Sci U S A (1994) 2.35

Portacaval shunt in patients with familial hypercholesterolemia. Ann Surg (1983) 2.33

The hepatotropic influence of cyclosporine. Surgery (1990) 2.27

SEROTYPING FOR HOMOTRANSPLANTATION. VII. SELECTION OF KIDNEY DONORS FOR THIRTY-TWO RECIPIENTS. Ann N Y Acad Sci (1966) 2.25

Human cadaveric renal transplantation. Report of twenty cases. Br Med J (1965) 2.12

Human renal transplants. I. Glomerular changes. Lab Invest (1967) 2.06

Augmentation of rat liver regeneration by FK 506 compared with cyclosporin. Lancet (1989) 2.01

Infections in recipients of liver homografts. N Engl J Med (1968) 1.92

The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91

Functional imprinting and epigenetic modification of the human SNRPN gene. Hum Mol Genet (1993) 1.84

Progress in homotransplantation of the liver. Adv Surg (1966) 1.83

Fungus infections after liver transplantation. Ann Surg (1977) 1.81

Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80

Platelet changes following clinical and experimental hepatic homotransplantation. Arch Surg (1968) 1.78

Serotyping for homotransplantation. V. Evaluation of a matching scheme. Transplantation (1966) 1.78

The quality of life after liver transplantation. Transplant Proc (1979) 1.78

Liver regeneration in dogs: morphologic and chemical changes. J Surg Res (1978) 1.78

Prognostic factors in sterile pancreatic necrosis. Gastroenterology (1992) 1.77

Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg Gynecol Obstet (1975) 1.74

Stimulation of hepatic regeneration after partial hepatectomy by infusion of a cytosol extract from regenerating dog liver. Surg Gynecol Obstet (1980) 1.72

Homotransplantation of the liver. Transplantation (1967) 1.71

Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology (1994) 1.70

Human renal transplants. II. Immunofluorescent and immunoferritin studies. Lab Invest (1968) 1.69

Auxiliary liver transplantation: effect of host portacaval shunt. Experimental and clinical observations. Arch Surg (1966) 1.66

Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66

The effect of splanchnic viscera removal upon canine liver regeneration. Surg Gynecol Obstet (1978) 1.63

Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet (1975) 1.55

The effect of partial portacaval transposition on the canine liver. Surgery (1967) 1.54

Renal homotransplantation with venous outflow or infusion of antigen into the portal vein of dogs or pigs. Transplantation at portal site. Transplantation (1977) 1.54

Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53

Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. JPEN J Parenter Enteral Nutr (1990) 1.53

Liver replacement for pediatric patients. Pediatrics (1979) 1.51

Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet (1969) 1.51

Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50

Decline in survival after liver transplantation. Arch Surg (1980) 1.39

Autopsy findings in a long-surviving liver recipient. N Engl J Med (1973) 1.36

Pathology of liver transplantation. Transplant Rev (1969) 1.36

The specific influence of nonhepatic splanchnic venous blood flow on the liver. Surg Forum (1965) 1.34

The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet (1975) 1.33

Virus-induced obstruction of the ureteric and cystic duct in allograft recipients. Transplant Proc (1973) 1.33

Human renal transplants. 3. Immunopathologic studies. Lab Invest (1970) 1.31

Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci (1975) 1.30

Liver transplantation of Budd-Chiari syndrome. JAMA (1976) 1.26

Factors influencing postoperative urinary retention in patients undergoing elective inguinal herniorrhaphy. Am J Surg (1991) 1.21

Renal transplantation in children. Analysis of 25 consecutive transplants in 19 recipients. Arch Dis Child (1972) 1.20

Significance of haematuria in hypertensive patients. Lancet (1980) 1.16

A decade followup in early cases of renal homotransplantation. Ann Surg (1974) 1.16

Studies of the hepatotrophic qualities of FK 506 and CyA. Transplant Proc (1990) 1.14

Studies on mechanisms of augmentation of liver regeneration by cyclosporine and FK 506. Hepatology (1991) 1.13

Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg (1976) 1.11

The effect upon the liver of evisceration with or without hormone replacement. Surg Gynecol Obstet (1978) 1.11

The clinical use of antilymphocyte globulin in renal homotransplantation. Transplantation (1967) 1.09

Chronic renal homograft function: correlation with histology and lymphocyte antigen matching. Am J Med (1967) 1.08

Immunopathological studies of orthotopic human liver allografts. Lancet (1972) 1.07

Mucin-producing carcinoid ("composite tumor") of upper third of esophagus: a variant of carcinoid tumor. Cancer (1979) 1.05

Eleven and two-thirds years' survival after canine orthotopic liver transplantation. Transplantation (1977) 1.04

Hepatotrophic properties in dogs of human FKBP, the binding protein for FK506 and rapamycin. Transplantation (1991) 1.01

Variation in the progression of diabetic nephropathy according to racial origin. Nephrol Dial Transplant (2001) 1.01

Sclerosing orbital pseudotumor. Neurosurgery (1983) 1.01

Inhibition of liver, kidney, and intestine regeneration by rapamycin. Transplantation (1992) 1.00

Factors influencing urinary tract retention after elective open cholecystectomy. Surg Gynecol Obstet (1992) 1.00

Vector potential of houseflies (Musca domestica) for Helicobacter pylori. J Clin Microbiol (1997) 0.99

Liver transplantation--1978. Transplant Proc (1979) 0.99

Hyperacute rejection of a transplanted human heart. Transplantation (1981) 0.98

Thymectomy and renal homotransplantation. Clin Exp Immunol (1970) 0.98

Net histocompatibility ratios (NHR) for clinical transplantation. Transplant Proc (1971) 0.97

Correction of coagulation in the hemophilic dog by transplantation of lymphatic tissue. Surgery (1974) 0.94